See analyst estimates and all valuation multiples for Drug Delivery Systems
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $23.7B | 9.6x | 41.0x | |
| $7.8B | 5.9x | 23.7x | |
| $5.3B | 212.2x | -5.1x | |
| $4.8B | n/a | n/a | |
| $4.0B | 16.0x | 41.3x | |
| $3.8B | 3.3x | 11.9x | |
| $2.3B | 42.3x | n/a | |
| $1.8B | 32.1x | -7.7x | |
| $1.5B | 4.8x | n/a | |
| $1.3B | n/a | n/a | |
| $754M | 21.8x | -89.2x | |
| $709M | 8.7x | -236.1x | |
| $703M | 18.2x | -4.4x | |
| $438M | 37.9x | -251.0x | |
| $322M | n/a | n/a | |
| $314M | 5.0x | -5.7x | |
| $305M | 3.9x | 18.7x | |
| $246M | 6.0x | -11.7x | |
| $225M | 490.4x | -7.5x | |
| $205M | n/a | n/a | |
| $205M | n/a | n/a | |
| $167M | 39.8x | -1.3x | |
| $124M | 5.8x | -65.2x | |
| $83.5M | n/a | n/a | |
| $79.2M | 30.8x | n/a | |
| $76.2M | n/a | n/a | |
| $72.5M | 205.9x | n/a | |
| $71.3M | n/a | n/a | |
| $54.1M | 12.2x | -2.4x | |
| $49.5M | 395.7x | n/a | |
| $44.2M | n/a | n/a | |
| $39.6M | 6.5x | -9.9x | |
| $34.2M | 82.6x | n/a | |
| $33.0M | 36.1x | n/a | |
| $32.8M | n/a | n/a | |
| $25.7M | n/a | n/a | |
| $19.7M | n/a | -1.3x | |
| $19.2M | 28.4x | n/a | |
| $16.2M | n/a | n/a | |
| $14.0M | n/a | n/a | |
| $9.8M | 4.0x | -0.5x | |
| -$1.9M | -0.5x | n/a | |
| -$3.1M | -2.2x | n/a | |
| -$106M | -1.2x | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Drug Delivery Systems